Since 2011, when the United States Food and Drug Administration (U.S. FDA) approved ipilimumab (Yervoy®) for malignant melanoma, several immune-checkpoint inhibitors have been granted marketing authorisation. Do you know all the indications? MediPaper made an overview of all the U.S. FDA approved immune-checkpoint inhibitors and other U.S. FDA approved immunotherapies.
How to shorten the recovery of surgical patients and reduce the incidence of postoperative complications? TIVA is a multimodal approach aimed at the reduced utilization of opioids and enhanced recovery of the surgical patient. Professor Xue held an expert lecture on the principles of TIVA during the 25th Annual Meeting of the Chinese Society of Anesthesiology.
MediPaper Healthcare Writers | Digital Medical Marketing | Portfolio | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | Medical Communications Health Blog | Medical Writer Jobs